
Dapazin 5mg Tablet
Marketer
Zivago Pharma Private Limited
Salt Composition
Dapagliflozin (5mg)
Overview Dapazin 5mg Tablet
Glucozym 5mg tablets are indicated for managing type 2 diabetes, either independently or as part of a multi-drug regimen. Its mechanism lowers elevated blood glucose, thus mitigating the risk of severe diabetic complications and cardiovascular events. Glucozym 5mg may be administered with or without food, consistently at the same time each day, as directed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation can lead to hyperglycemia and potentially serious consequences such as renal impairment and vision loss. This medication forms one element of a comprehensive treatment plan, encompassing a doctor-recommended diet, exercise, and weight management strategy. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections. Excessive fluid loss is possible; ensure adequate hydration to prevent dehydration. Practicing good hygiene minimizes the risk of genital infections. Prior to commencing treatment, inform your doctor about any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use. Expectant or nursing mothers should seek medical counsel before use. Limit alcohol consumption while on this medication to reduce the likelihood of side effects. Regular blood glucose monitoring is crucial during treatment.
Uses of Dapazin 5mg Tablet
Managing Type 2 Diabetes
Major Benefits of Dapazin 5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapazin 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Dapazin 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapazin 5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapazin 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Dapazin 5mg Tablet works:
Dapazin 5mg tablets are used to manage diabetes. Their mechanism of action involves the excretion of surplus glucose via the urine.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Dapazin 5mg tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Dapazin 5mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapazin 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Dapazin 5mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Seek medical advice.
LiverSAFE IF PRESCRIBED
Dapazin 5mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dapazin 5mg Tablet :
Should you forget to take your Dapazin 5mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapazin 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
